<DOC>
	<DOC>NCT01256138</DOC>
	<brief_summary>Allogene MSCs transplantation will be performed in patients with chronic liver diseases through portal vein by ultrasound guiding and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.</brief_summary>
	<brief_title>Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>1. chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune liver disease. 2. age: 1565 years old. 1. pregnant women and women in lactation. 2. other systems and organs disfunction 3. spaceoccupying lesion were found in liver. 4. concurrent infection with HIV and other immunodeficiency diseases. 5. DIC and active bleeding were confirmed.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Allogene MSCs</keyword>
	<keyword>transplantation</keyword>
	<keyword>chronic liver diseases</keyword>
	<keyword>portal vein</keyword>
</DOC>